Management of Multiple Drug-Resistant Infections

ISBN-13: 9781617374388 / Angielski / Miękka / 2010 / 403 str.

Ed. Stephen H. Gillespie

Opis

A comprehensive and cutting-edge review of how practicing physicians can best treat multiple drug resistance in bacterial, viral, protozoal, and helminthic infections. The authors focus on the major hospital and community-acquired pathogens, including S. aureus, S. pneumoniae, Enterococcus, Acinetobacter, and M. tuberculosis, and on the management of such common problems as multiple drug-resistant urinary tract infections and gonorrhea. Among the resistant tropical organisms covered are Salmonella typhi, malaria, and Burkholderia pseudomalei. Resistance to such important antiviral classes as antiretrovirals and anticytomegalovirals is also discussed, as are those measures necessary to prevent the spread of infections patients.

Recenzje

"...highlights include excellent chapters on the management of multidrug-resistant malaria and drug-resistant infections caused by the human immunodeficiency virus...a book that will be an enjoyable and useful reference for physicians and microbiologists who are interested in developing a better grasp of this complex and rapidly changing field." -The New England Journal of Medicine

"...excellent, concise discussions of treatment of resistant urinary tract infections, Salmonella infections, melioidosis, and malaria." - American College of Physicians

Spis treści

Part I: Gram-Positive Bacteria Management of Community-Acquired Pneumonia Caused by Drug-Resistant Streptococcus pneumoniae Eric L. Nuermberger and William R. Bishai Management of Meningitis Caused by Resistant Streptococcus pneumoniae P. Fernández Viladrich Emerging Resistance to Vancomycin, Rifampin, and Fluoroquinolones in Streptococcus pneumoniae Joseph M. Blondeau Management of Glycopeptide-Resistant Staphylococcus aureus Infections A. Peter R. Wilson Infections Caused by Glycopeptide-Resistant Gram-Positive Bacteria Excluding Staphylococci Armine Sefton Isolation Policies and the Hospital Management of Methicillin-Resistant Staphylococcus aureus: A Case of Evidence-Free Medicine? Sheldon P. Stone Part II: Gram-Negative Pathogens The Management of Resistant Acinetobacter Infections in the Intensive Therapy Unit Nicola Baker and Peter Hawkey Drug-Resistant Helicobacter pylori Peter J. Jenks The Management of Antibiotic-Resistant Neisseria gonorrhoeae Catherine A. Ison and Jonathan Ross Management of Urinary Tract Infections Caused by Multiresistant Organisms Jeremy M. T. Hamilton-Miller Management of Multiple Drug-Resistant Salmonella Infections Christopher M. Parry Management of Melioidosis Andrew J. H. Simpson Part III: Mycobacteria The Molecular Epidemiology of MDR-TB Paul D. van Helden, Robin M. Warren, Pieter Uys, Gian D. van der Spuy, and Thomas C. Victor The Management of Multiple Drug-Resistant Tuberculosis Sanjay Bhagani and Marc Lipman Management of Infection With Nontuberculosis Mycobacteria Stephen H. Gillespie Part IV: Fungal and Parasitic Infections Management of Resistant Candida Infections Sanya Clements and Christopher C. Kibbler Management ofInfection With Naturally Amphotericin B-Resistant Fungi Thean Yen Tan and Rosemary A. Barnes Management of Multiple Drug-Resistant Malaria Elizabeth Ashley and François Nosten Schistosome Drug Resistance: Praziquantel Michael J. Doenhoff and Katherine Wheatcroft-Francklow Part V. Viral Infections Management of HIV Drug-Resistant Infections Deenan Pillay Multidrug Resistance in Human Cytomegalovirus Vincent C. Emery, Mohammad Raza Naqvee, and Anuradha Chawla Index

Blurb

Multiple drug resistance to antimicrobials is a growing problem that limits the effective lifetime of nearly all drugs developed against microorganisms. In Management of Multiple Drug-Resistant Infections, prominent clinicians and leading microbiologists describe how practicing physicians can best treat bacterial, viral, protozoal, and helminthic infections when there is significant resistance to antibiotics. The authors focus on the major hospital and community-acquired pathogens, including S. aureus, S. pneumoniae, Enterococcus, Acinetobacter, and M. tuberculosis, and on the management of such common problems as multiple drug-resistant urinary tract infections and gonorrhea. Among the resistant tropical organisms covered are Salmonella typhi, malaria, and Burkholderia pseudomalei. Resistance to such important antiviral classes as antiretrovirals and anticytomegaloviral agents is also discussed, as are those measures necessary to prevent the spread of infections among patients. When national or international treatment guidelines cannot be established, clinical trial data, in vitro susceptibility data, and epidemiologic and pharmacological evidence are cited to help make treatment decisions. Wherever possible, the question of drug resistance is set in the context of its biology and epidemiology.
Comprehensive and practice-oriented, Management of Multiple Drug-Resistant Infections offers physicians and clinical microbiologists treating infectious disease patients not only a critically evaluated guide to the immense literature of the field, but also an up-to-date practical survey of today's gold-standard therapeutic strategies.